Parameter
| Biomarker | Platelet - Lymphocyte thewire (PLR) | Full name | Platelet-to-Lymphocyte Ratio | Molecular Type | Hematology indexes |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis and prediction of immune-related adverse reactions | ||
| Disease | Hepatocellular Carcinoma (HCC) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Whole blood (routine blood test) | ||
| Pathobiological Mechanisms | Reflect inflammatory and blood coagulation state, high PLR suggests tumor progression increased risk | ||||
| Clinical Availability Status | This study verified that PLR>300 was an independent risk factor for irAEs (≥ grade 2) | ||||
| Notes and Dynamics | The combination of PLR and NLR can optimize the prognostic stratification efficiency | ||||